Cancer Drug Trastuzumab And Its Biosimilars Market Share (IMAGE)

University of Southern California

Cancer Drug Trastuzumab And Its Biosimilars Market Share

Caption

Number of Medicare claims for trastuzumab originator (Herceptin) and 5 biosimilars, by month, 2019–20

Credit

Health Affairs

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.